Jun 28, 2016 by Brian FeroldiInstant Analysis: Gilead Sciences Wins an Important FDA ApprovalShares jump on the news that the FDA has approved the company's newest hepatitis C treatment. Could this be the start of a turnaround for Gilead's shares?
Jun 28, 2016 by Brian FeroldiACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's WhyShares plunged to start the year and then came roaring back to life. Here's a recap of the major news items that have driven the company's stock in 2016.
Jun 28, 2016 by Brian FeroldiForget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy InsteadInvestors in stem cell stocks have been bludgeoned for several years now, and I think the entire space is un-investable.
Jun 27, 2016 by Brian FeroldiWhen Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?All three of stocks started the year trading for over $100, but that's no longer the case. Here's what it's going to take for each one climb back above the triple-digit threshold.
Jun 24, 2016 by Brian Feroldi3 Biotech Stocks to Buy in the Wake of the Brexit VoteBiotechnology stocks are getting slammed after Britain voted to leave the E.U. Here are three high-quality biotechnolgy stocks to buy in the wake of the market wide sell off.
Jun 24, 2016 by Brian FeroldiMannKind Corp. Shares Are Down 28.3% So Far This Year. Here's Why.A series of announcements have sent the company's shares on a roller coaster ride this year. Here's a recap of what has happened so far, and some advice for investors considering climbing on board.
Jun 24, 2016 by Brian FeroldiKeryx Biopharmaceuticals Has Gained 19.8% So Far in 2016 -- Here's WhyGood news mixed with a beaten-down stock price has caused shares to bounce back in 2016.
Jun 23, 2016 by Brian Feroldi$18,543 Invested in This Biotech a Decade Ago Is Now Worth $1 MillionFor biotech investors, this is about as good as it gets.
Jun 22, 2016 by Brian FeroldiHere's Why Intuitive Surgical Is Up 18% in 2016With shares trading near all-time highs, it's been six months of good news.
Jun 21, 2016 by Brian Feroldi7 Pharmaceutical Stocks With Dividends Yielding More Than 3%Drug companies tend to offer investors some of the highest dividend yields in the healthcare sector. But only two of the seven pharmaceutical stocks currently yielding more than 3% are worth buying.
Jun 21, 2016 by Brian FeroldiWhy Medgenics Inc.'s Shares Are Down Big TodayNews of a share offering at unfavorable prices caused some traders to hit the sell button.
Jun 20, 2016 by Brian FeroldiCerus Corporation is Surging Today. Here's Why.Shares of the blood-transfusion specialist are on the move after news broke that it has won a lucrative government contract.
Jun 20, 2016 by Brian Feroldi, Steve Symington, and Timothy GreenThe Single Best Stock to Own TodayOur team of contributors think that these three stocks are compelling buys right now.
Jun 20, 2016 by Brian Feroldi3 Ways to Earn Double-Digit Returns on Your Money -- GuaranteedLooking for a few easy ways to guarantee yourself a high rate of return? Here are three ideas you might want to consider.
Jun 18, 2016 by Brian FeroldiForget TransEnterix Inc: This is The Company That Intuitive Surgical Investors Should Fear MostThe FDA's rejection of TransEnterix's SurgiBot System has removed a potential threat, but there's another competitor on the horizon that Intuitive Surgical's investors need to keep tabs on.
Jun 17, 2016 by Brian Feroldi5 Secret Medicare Benefits That All Retirees Should KnowMake sure you are aware of all of the benefits that Medicare offers.
Jun 16, 2016 by Brian FeroldiThis Retailer Is Amazon-ProofBrick-and-mortar retailers are under huge pressure right now from e-commerce companies like Amazon, but this retailer's business is about as Amazon-proof as it gets.
Jun 15, 2016 by Brian Feroldi, Dan Caplinger, and Andrés Cardenal3 Warren Buffett Stocks to Buy in JuneHere's why out team of Foolish contributors think these three Warren Buffett holdings are buys right now.
Jun 14, 2016 by Brian FeroldiWhy Infinity Pharmaceuticals Inc. Is Being Obliterated TodayDisappointing results from a clinical trial cause traders to head for the exits.
Jun 13, 2016 by Brian FeroldiThe Reason Behind TransEnterix Inc.'s 22% Jump in MayShares soared during the month of May, but big questions remain unanswered about where it goes from here.
